STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] INNOSPEC INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Innospec Inc. director reports open-market stock purchase

A director of Innospec Inc. (IOSP) reported buying 340 shares of the company’s common stock on 11/14/2025 at a price of $74.09 per share. After this transaction, the director beneficially owns 5,837 shares, held as a direct ownership position. The transaction was reported on a Form 4 as a purchase coded "P" in the non-derivative securities table, and no derivative security transactions were reported.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PARRETTE LESLIE J

(Last) (First) (Middle)
8310 SOUTH VALLEY HIGHWAY
SUITE 350

(Street)
ENGLEWOOD CO 80112

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INNOSPEC INC. [ IOSP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/14/2025 P 340 A $74.09 5,837 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Leslie J. Parrette 11/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Innospec Inc. (IOSP) report on this Form 4?

The filing reports that a director of Innospec Inc. (IOSP) purchased 340 shares of common stock on 11/14/2025.

At what price were the Innospec (IOSP) shares purchased in this insider trade?

The director bought the 340 shares of Innospec common stock at a price of $74.09 per share.

How many Innospec (IOSP) shares does the director own after the reported transaction?

Following the reported purchase, the director beneficially owns 5,837 shares of Innospec common stock.

What is the relationship of the reporting person to Innospec Inc. (IOSP)?

The reporting person is a director of Innospec Inc., as indicated in the relationship section of the filing.

Was this Innospec (IOSP) insider trade reported as a direct or indirect holding?

The 5,837 shares owned after the transaction are reported as a direct ownership position.

Does this Form 4 for Innospec (IOSP) report any derivative security transactions?

No derivative securities are listed as acquired or disposed of; only a purchase of common stock is reported in the non-derivative table.

Innospec Inc

NASDAQ:IOSP

IOSP Rankings

IOSP Latest News

IOSP Latest SEC Filings

IOSP Stock Data

1.79B
24.46M
1.26%
99.52%
1.27%
Specialty Chemicals
Chemicals & Allied Products
Link
United States
ENGLEWOOD